
Explore the details: https://bit.ly/4jq1eUD
Higher OCB counts in newly diagnosed MS were linked to broader MRI lesion spread and poorer verbal learning and memory.
Get the scoop: https://bit.ly/4dF2WxI
Thinning of a layer of nerve cells in the eye's retina was associated with slower cognitive processing in people with MS, per a study.
Take a closer look: https://bit.ly/4i0Zjn9
Like Bilbo Baggins, columnist Ben Hofmeister has "things to do," and says it is time to say farewell to his excellent and admirable readers.
Falls involve many factors at once. In this qualitative study, 25 PwMS were interviewed soon after their falls (94 total). The authors suggest taking a broader fall history and building rehab around each person, so they can better judge their risk.
doi.org/10.7224/1537...
#MultipleSclerosis #falls
Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.
Neurology
This week in Multiple Sclerosis and Neuroimmunology: palamedesreport.org/this-week/multiple-sclerosis
pubmed.ncbi.nlm.nih.gov/42832743
Multiple sclerosis (MS) is a persistent immune-mediated condition marked by neuroinflammation, demyelination, and ongoing neurological impairment. Although there have been advancements in therapies aimed at modifying the disease, signifi...
#MSchat #MS #Neurology #MultipleSclerosis #NeuroSky #MedSky
A common symptom of multiple sclerosis is brain fog.
But brain fog isn’t as easy to describe.
It’s multifaceted. Unpredictable. You learn to adapt, but it’s still a quagmire.
Brain fog doesn’t always feel like fog.
Sometimes it feels like certainty.
An abundance of caution is on hold while I demonstrate my need for your donations and support. Garage Dayz October, pt. 2 is tomorrow! #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
Cleared by my doctor, provided I assume an abundance of caution. Let’s see how this goes! #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK
Quantum BioPharma (NASDAQ: QNTM) receives FDA clearance to begin Phase 2 trials for Lucid-MS, a novel multiple sclerosis therapy that protects nerve cells by targeting myelin damage — not the immune system. A potentially distinct approach to MS treatment. #MultipleSclerosis #Biopharma
Explore the key research topics and clinical advances that will shape discussions at #MSToronto2026, the joint ACTRIMS/ECTRIMS meeting on MS and related disorders.
Get the scoop: https://bit.ly/4yKBqHx
Briumvi may be more effective than Kesimpta or Ocrevus at preventing disability progression in relapsing MS, an indirect comparison shows.
Selma Blair released on bail after pleading not guilty to assault charges following in-flight incident
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#assault #flightincident #multiplesclerosis
👇👇👇
Ask an MS Expert Video — Managing #Depression With MS — about half of people w #MultipleSclerosis experience it
Learn coping strategies & treatments to help manage depression w Dr. Anthony Feinstein, professor of psychiatry at Univ. of Toronto, specializing in MS.
Prerecorded: tinyurl.com/3tazdjxc
miguelallamani.com/tuesday-play...
The Tuesday Playbook is live. Get into it, people.
Ordinary life with MS. Short, usable pieces by someone with brain fog, for people who know what it’s like to lose their place.
Take what fits. Share it.
Discover more: https://bit.ly/4hL90Hy
Reduced immune responses to the Epstein-Barr virus may help explain the efficacy of anti-CD20 therapy in people with MS, per a study.
The verdict is on my foot, kind of… #NeverStopNeverQuitForThem #MultipleSclerosis #MS #nationalmssociety #CanYouTRK